BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PPARA
,
Response to oxidative stress
,
Inflammatory disorder
,
Pancreas
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
6 -
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Pediatric Thromboelastograph 6s and Laboratory Coagulation Reference Values.
Thromboelastography 6s for assessment of platelet function during coil embolization of unruptured in…
The Gonadotropin-Releasing Hormone Analogue Therapy May Not Impact Final Height in Precocious Pubert…
Magnitude and predictors of malnutrition among internally displaced persons' children 6 - 59 months …
Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Photoallergic Potential of 6% Bemotrizinol
Phototoxicity Potential of 6% Bemotrizinol
Klotho _ LRP-6 _ Gastric Adenocarcinoma
Corheart 6 VAS Study
The PROMISE Pediatric Study 6 to 11 Years Old
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ